Bevacizumab (ophthalmic)

  • Biologic
  • LYTENAVA

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Bevacizumab (ophthalmic): storage and handling

Refrigerate
Yes, as the label states
Label statement
Store LYTENAVA refrigerated at 2ºC to 8ºC (36ºF to 46ºF) in the original carton until use to protect from light.
Freezing
Do not freeze
Label statement
DO NOT FREEZE.
Room temperature
up to 12 hours
Label statement
Prior to use, the unopened glass vial of LYTENAVA may be kept at room temperature, 20ºC to 25ºC (68ºF to 77ºF), for up to 12 hours.
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Store LYTENAVA refrigerated at 2ºC to 8ºC (36ºF to 46ºF) in the original carton until use to protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Beyond the room-temperature allowance the label states. The label does not state stability beyond it.

Entered: 1 day at up to 77°F (25°C).

Prior to use, the unopened glass vial of LYTENAVA may be kept at room temperature, 20ºC to 25ºC (68ºF to 77ºF), for up to 12 hours.

Contact the manufacturer about this product; the label text ClinDose has does not print a phone number for it.

All storage statements on the label (3)
  • Store LYTENAVA refrigerated at 2ºC to 8ºC (36ºF to 46ºF) in the original carton until use to protect from light.
  • DO NOT FREEZE.
  • Prior to use, the unopened glass vial of LYTENAVA may be kept at room temperature, 20ºC to 25ºC (68ºF to 77ºF), for up to 12 hours.

FDA label version 1, effective July 16, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.